The Science Behind Neuromodulation for Persistent Pain

Neurostimulation for Chronic Pain How This Treatment Targets Nerve Signals

Neurostimulation for chronic pain management is a therapy that uses mild electrical pulses to interrupt pain signals before thync global they reach your brain, offering a powerful alternative to medication. It works by targeting specific nerves or spinal cord areas, effectively « distracting » your nervous system from processing persistent pain. The key benefit is that it provides a drug-free way to reclaim daily comfort, often giving people back control over activities that pain had stolen.

The Science Behind Neuromodulation for Persistent Pain

Imagine your nervous system as a faulty alarm, screaming « pain » long after tissue heals. Neuromodulation for persistent pain targets this misfire directly. By implanting an electrode near the spinal cord or peripheral nerves, neurostimulation for chronic pain management delivers precise electrical pulses. These pulses interrupt pain signals before they reach the brain, effectively « shushing » the hyperactive nerves. The science hinges on the gate control theory: stimulation activates large-diameter nerve fibers that essentially close a neural gate, blocking the smaller pain-carrying fibers. For you, this means the sensation shifts from agonizing burning to a manageable tingle—your brain registers the stimulation, not the original pain. This isn’t a cure; it’s a real-time override, restoring function where drugs failed.

How Targeted Electrical Signals Alter Pain Perception

Targeted electrical signals alter pain perception by engaging the Gate Control Theory, where specific frequencies preferentially activate large-diameter Aβ nerve fibers. This rapid, non-painful input effectively « closes the gate » in the spinal dorsal horn, blocking slower, pain-carrying C-fiber signals from ascending to the brain. Concurrently, these precisely timed pulses modulate descending inhibitory pathways from the periaqueductal gray, releasing endogenous opioids like enkephalin. This dual mechanism—peripheral gating and central neurochemical release—creates an immediate sensory-level interference pattern that overwrites nociceptive transmission, reducing perceived pain intensity without masking or sedation.

Targeted electrical signals override pain pathways by closing spinal gates and triggering opioid release, directly substituting aberrant pain signals with controlled, non-nociceptive input.

Key Mechanisms: Gate Control Theory and Central Sensitization

The gate control theory explains how neurostimulation closes the spinal « gate » by preferentially activating large-diameter Aβ fibers, which block pain signals carried by smaller Aδ and C fibers from reaching the brain. Central sensitization, conversely, amplifies pain through persistent neuronal hyperexcitability in the dorsal horn. Neuromodulation counters this by delivering electrical pulses that normalize abnormal firing patterns, reducing wind-up and long-term potentiation. It effectively recalibrates maladaptive plasticity, restoring balance to pain-processing circuits. By shutting the spinal gate and dampening central hypersensitivity, these mechanisms directly interrupt the chronic pain cycle at its neural source.

The Role of Neuroplasticity in Long-Term Relief

Neurostimulation leverages activity-dependent neuroplasticity to rewire maladaptive pain circuits, shifting the brain from a chronic pain state to a normalized processing pattern. Over weeks of consistent stimulation, the central nervous system learns to dampen hyperexcitability and reduce the synaptic strength of pain signals. This structural reorganization is what transforms temporary symptom suppression into durable, long-term relief. As the brain’s neural networks physically adapt, patients often experience a gradual reduction in pain intensity, even during periods when the device is off. Essentially, neuroplasticity consolidates the therapeutic gains, making relief self-sustaining rather than device-dependent.

Types of Electrical Stimulation Therapies Available Today

For chronic pain management, current electrical stimulation therapies offer distinct non-invasive and implantable options. Transcutaneous Electrical Nerve Stimulation (TENS) uses surface electrodes for acute, localized pain relief through high-frequency pulses. Spinal Cord Stimulation (SCS) involves an implanted device delivering low-voltage current directly to the dorsal column to disrupt pain signals before they reach the brain. For targeted nerve pain, Peripheral Nerve Stimulation (PNS) provides a lead placed near a specific nerve, while Peripheral Nerve Field Stimulation (PNFS) treats regional areas. These neurostimulation therapies allow patients to adjust intensity via a remote, offering a reversible, drug-free alternative that directly modulates the nervous system’s pain pathways.

Spinal Cord Stimulation: Electrodes Along the Spine

Spinal cord stimulation with electrodes along the spine delivers targeted electrical pulses directly to the dorsal columns of the spinal cord, intercepting pain signals before they reach the brain. Tiny leads are carefully placed in the epidural space during a minimally invasive procedure, allowing you to test the therapy with an external trial stimulator before committing to a permanent implant. Once active, you control the intensity and frequency via a handheld remote or smartphone app. The electrical paresthesia—a gentle tingling—replaces the sensation of chronic pain, enabling you to stand longer, walk with less discomfort, and reduce reliance on oral medications.

Peripheral Nerve Stimulation: Addressing Localized Pain Sources

Peripheral Nerve Stimulation (PNS) targets chronic pain by delivering electrical pulses directly to afferent nerve fibers near the injury site, bypassing the central nervous system. Unlike spinal cord stimulation, PNS uses external or small implanted leads placed percutaneously along a peripheral nerve trunk. This allows precise modulation of localized pain sources—such as post-surgical neuralgia or specific mononeuropathies—without systemic side effects. The therapy interrupts aberrant pain signals before they reach the dorsal root ganglion, effectively “filtering” nociceptive input at its origin. Clinical protocols emphasize lead placement within millimeters of the target nerve, requiring ultrasound or fluoroscopic guidance for accuracy. Stimulation parameters are adjusted to achieve paresthesia coverage solely over the painful dermatome, often yielding rapid analgesia within minutes of activation.

Transcutaneous Electrical Nerve Stimulation (TENS) for At-Home Use

For managing chronic pain at home, Transcutaneous Electrical Nerve Stimulation (TENS) for At-Home Use is a go-to, drug-free option. You simply place sticky electrode pads on your skin around the sore area and adjust the intensity with a small, battery-powered device. The mild pulses help block pain signals from reaching your brain. Here’s how to get started:

1. Apply electrodes to clean, dry skin near the pain site, avoiding broken skin.
2. Turn the unit on and slowly increase the intensity until you feel a strong but comfortable tingling.
3. Use it for 20–30 minutes per session, up to several times a day as needed.

Deep Brain and Motor Cortex Stimulation for Refractory Cases

For truly stubborn pain that resists all other treatments, doctors sometimes turn to deep brain and motor cortex stimulation for refractory cases. This involves surgically placing electrodes either deep inside the brain or on the surface of the motor cortex to directly alter pain signals. The goal isn’t to erase pain, but to dial down its intensity so you can function better. It’s typically a last-resort option, considered only after less invasive therapies have failed over many years. Recovery involves fine-tuning the stimulation settings with your neurologist over several weeks to find what works for you.

Evaluating Candidacy: Who Benefits Most From This Approach

The ideal candidate for neurostimulation often carries a story of specific, localized pain—like a persistent burn in a limb from failed back surgery or a deep ache in a joint from complex regional pain syndrome. These individuals have typically cycled through oral medications, injections, and physical therapy, yet the pain remains a constant narrative in their daily life. The patients who benefit most are those with neuropathic pain origins, where the nervous system itself malfunctions, not those with widespread, inflammatory conditions like fibromyalgia. A key pre-trial often reveals their story: a temporary reduction in pain during a spinal cord stimulator trial, confirming the brain can be “interrupted” from hearing the chronic pain signal.

Those who maintain mental flexibility and realistic expectations for a 50–70% reduction, rather than a cure, weave the best outcomes into their ongoing life story.

The approach fails for individuals with untreated psychological distress or secondary gain, as the device becomes a subplot that cannot resolve the deeper narrative.

Patient Profiles: Failed Back Surgery Syndrome and Neuropathic Conditions

Patients with Failed Back Surgery Syndrome (FBSS) who present with persistent radicular pain despite prior surgical intervention are prime candidates, as neurostimulation directly targets the dorsal columns to override aberrant signals. For neuropathic conditions such as diabetic peripheral neuropathy, candidacy hinges on a confirmed small-fiber or large-fiber lesion causing non-noxious paresthesia. Unlike nociceptive pain, these profiles require that a trial lead placement reproduces the patient’s specific pain topography before permanent implantation. A history of multiple spine operations or refractory mononeuropathy must correlate with electrophysiological or imaging evidence of nerve compromise.

Patient profiles for FBSS and neuropathic conditions are defined by post-surgical or lesion-specific neuropathic pain that is anatomically reachable by electrode stimulation, with trial success contingent on precise paresthesia overlap.

Psychological Screening and Realistic Outcome Expectations

Psychological screening before neurostimulation is non-negotiable, as it identifies factors like untreated depression or catastrophizing that directly sabotage outcomes. This process filters for candidates who can engage with the device, not just hope for a cure. Realistic outcome expectations are then calibrated through shared dialogue, clarifying that pain reduction often hovers at 50-70%, not total elimination. Patients who mistake relief for a reset tend to suffer greater disappointment and device abandonment. The screening also assesses support systems and coping strategies, ensuring the individual can manage daily device adjustments and potential side effects without spiraling into distress.

Contraindications and Risk Factors to Consider

Evaluating candidacy requires rigorous assessment of absolute contraindications, including active infection at the implant site, untreated coagulopathy, or inability to provide informed consent. Risk factors that complicate outcomes include significant psychological comorbidities, such as untreated depression or somatization, which reduce tolerance for therapy. Prior spinal fusion or implanted hardware may interfere with lead placement and stimulation paresthesia coverage. Key considerations follow this sequence:

1. Confirm no MRI-dependent implants are present if the neurostimulator is not MRI-conditional.
2. Rule out opioid-induced hyperalgesia or substance use disorders that confound pain evaluation.
3. Assess for progressive neurological disorders (e.g., multiple sclerosis) that could alter lead stability.

These factors directly predict therapy failure or adverse events.

Procedure Overview: From Trial to Permanent Implant

The process begins with a temporary trial phase, where thin leads are placed near your spine and connected to an external stimulator you wear for a few days. This lets you test if the tingling sensations effectively mask your chronic pain before committing further. If you get meaningful relief, you move to the permanent implant, where a small generator is placed under the skin (usually your lower back or buttock) and the leads are secured. The whole procedure is typically done under sedation, not general anesthesia. Recovery from implantation feels more like deep soreness than sharp pain, easing over a week or two. You’ll likely return to normal activities gradually, following your doctor’s guidelines for bending and lifting.

The Temporary Trial Phase: Predicting Success Before Commitment

The temporary trial phase is a critical predictor of long-term success, transforming uncertainty into informed action before permanent implantation. During this brief period, a percutaneous lead delivers paresthesia to the targeted nerve fibers, allowing you to assess pain relief in real-world conditions. Achieving a 50% or greater pain reduction during the trial strongly correlates with lasting outcomes, making this the definitive benchmark for commitment. You actively test stimulation programs and adjust settings, directly experiencing how neurostimulation integrates with daily activities. This therapeutic preview eliminates guesswork, ensuring only those with proven benefit proceed to the permanent system.

Surgical Implantation of Leads and Pulse Generator

The surgical implantation of leads and a pulse generator is a permanent solution following a successful trial. Leads are placed via a needle or small laminotomy into the epidural space over the targeted spinal nerve roots, with intraoperative testing to confirm paresthesia coverage over the pain area. The pulse generator is then implanted subcutaneously, often in the upper buttock or abdomen, and tunneled leads connect to it. This procedure requires general sedation and typically causes postoperative soreness, with activity restrictions for several weeks to allow proper lead anchoring. Lead migration remains a key risk, managed through careful surgical technique and strain-relief loops.

Q: How long does surgical implantation of leads and pulse generator take?
A: The procedure usually lasts one to two hours, though time varies based on the number of leads and patient anatomy.

Programming Sessions: Customizing Stimulation Parameters for Each User

Following implant, programming sessions involve iteratively adjusting stimulation parameters—amplitude, pulse width, and frequency—to map the paresthesia coverage precisely over the patient’s pain topography. The clinician uses a tablet-based programmer to conduct real-time patient feedback calibration, modifying each parameter incrementally while the user reports sensation location and intensity. Parameters are saved as distinct programs, enabling the patient to later switch between settings for different activities or pain patterns. This session establishes the baseline therapeutic window: the amplitude range where stimulation is effective but not uncomfortable. Any subsequent reprogramming refines these initial values based on the user’s evolving neural response and pain distribution.

Post-Operative Recovery and Activity Adjustments

Following the trial implant, the permanent procedure requires a strict six-week activity adjustment period to ensure proper lead anchoring and tissue healing. Activity restrictions during neurostimulation recovery begin with avoiding bending, twisting, or lifting over ten pounds to prevent lead migration. A clear sequence of milestones guides your return:

1. Weeks 1–2: rest at home, no driving or prolonged sitting.
2. Weeks 3–4: gentle walking is permitted, but avoid overhead reaching or sudden movements.
3. Weeks 5–6: you may resume light daily tasks if approved, though strenuous exercise remains prohibited until a clinician’s clearance.

By strictly adhering to this schedule, you safeguard the system’s stability and maximize long-term pain relief outcomes.

Managing Outcomes: Efficacy, Side Effects, and Troubleshooting

Managing outcomes in neurostimulation for chronic pain hinges on systematic efficacy tracking and rapid side effect resolution. Patients should log pain relief percentage and functional gains daily during the initial programming phase, with a target of ≥50% reduction. Common side effects like uncomfortable paresthesia or muscle twitching are typically corrected by reprogramming stimulation parameters—adjusting frequency, pulse width, or electrode polarity—rather than abandoning therapy. Hardware issues, such as lead migration or battery depletion, require radiographic confirmation and surgical revision. Ineffective stimulation often stems from poor lead placement or fibrotic encapsulation, managed through rescue programming or salvage implant revision.

Immediate troubleshooting of discomfort preserves long-term neural tolerance and compliance, preventing failure from preventable adverse events.

Common Adverse Events: Lead Migration, Infection, and Battery Issues

Managing outcomes requires attention to common adverse events in neurostimulation. Lead migration alters paresthesia coverage, often requiring reprogramming or surgical revision. Infection risk peaks perioperatively, presenting as erythema or purulent drainage, and may necessitate explantation. Battery issues include premature depletion, charging failure, or device malfunction, disrupting therapy delivery. While lead migration and infection are anatomical, battery issues are technical, yet all three degrade efficacy. The table below compares their typical interventions.

Strategies for Reducing Unwanted or Overly Intense Sensations

When neurostimulation feels too zappy or intense, the first step is to adjust stimulation parameters directly on your remote. Lowering the amplitude or pulse width often dials back harsh sensations. If that alone doesn’t help, try swapping between preset programs; a different frequency or electrode configuration can spread the feeling more evenly. Another handy trick is repositioning the external battery or lead wire, as loose connections sometimes cause sharp, sudden jolts. You can also mark reprogramming as a solid backup plan—your clinician can tweak the contact points so the current targets pain pathways without hitting nearby nerves.

Long-Term Efficacy Data and Reasons for Treatment Discontinuation

Long-term efficacy data for neurostimulation reveal that while many patients sustain 50% or greater pain relief beyond two years, a notable subset experiences diminishing returns as conditions like tolerance or disease progression emerge. The most documented reasons for treatment discontinuation include loss of analgesic effect, hardware complications such as lead migration or battery failure, and psychological factors like frustration with inconsistent results. Treatment adherence drives long-term success, yet up to 30% of implants are explanted within five years due to inadequate paresthesia coverage or unexpected side effects like uncomfortable shocking sensations. Careful patient selection and proactive troubleshooting of lead placement are critical to minimizing dropout rates.

Long-term efficacy data show sustained relief in many, but discontinuation commonly stems from loss of effect, hardware issues, or psychological fatigue, making rigorous follow-up essential to reduce explant rates.

Integrating Electrical Stimulation With Other Pain Therapies

Integrating electrical stimulation with other pain therapies optimizes outcomes by targeting distinct pain mechanisms. Combining spinal cord stimulation with physical therapy enhances neuroplasticity, reducing central sensitization more effectively than either modality alone. For patients with neuropathic pain, pairing peripheral nerve stimulation with cognitive behavioral therapy addresses both the nociceptive drive and the emotional amplification of pain. Similarly, using transcutaneous electrical nerve stimulation alongside myofascial release or trigger point injections can preemptively reduce muscle guarding, allowing manual therapies to achieve greater range of motion. The clinical synergy lies in timing: applying electrical stimulation prior to exercise or manual therapy dampens acute pain signals, enabling participation in rehabilitative activities that would otherwise be intolerable.

A crucial insight: never stack modalities with identical analgesic mechanisms—pair electrical stimulation with therapies that target complementary pathways, such as descending inhibition (e.g., aerobic exercise) or cortical reorganisation (e.g., graded motor imagery).

Dose adjustments for both the stimulator and the co-therapy are essential to avoid overstimulation or desensitization.

Combining Physical Therapy and Medication Optimization

When pairing electrical stimulation with chronic pain care, combining physical therapy and medication optimization can supercharge your results. Physical therapy helps retrain muscles and improve movement patterns, while adjusting meds (like lowering NSAIDs or opioids) reduces side effects and lets the neurostimulation work better. For example, you might do targeted stretches during PT sessions, then use your stim device to calm flare-ups afterward. Meanwhile, your doctor could taper down painkillers as the therapy gains traction. This combo avoids over-reliance on drugs and builds long-term function—think of it as tuning both your body and your treatment plan for smoother progress.

Role of Cognitive Behavioral Techniques in Enhancing Results

Cognitive behavioral techniques directly boost outcomes by reshaping how patients mentally engage with their neurostimulation treatment plan. Instead of passively expecting relief, individuals learn to identify and reframe catastrophic thoughts about pain that can undermine electrical stimulation’s benefits. This mental shift helps patients adhere more consistently to their stimulation schedules and interpret variable responses without giving up. Practical CBT tools like paced activity and relaxation exercises also reduce the stress-driven tension that competes with stimulation, allowing the therapy to work more effectively.

• Teaches patients to challenge fear-based reactions that can block stimulation’s effect
• Improves consistent use of stimulation settings through structured behavioral routines
• Reduces emotional spikes that interfere with the brain’s receptivity to electrical input
• Helps users set realistic, incremental goals that align with stimulation’s gradual progress

Lifestyle Modifications That Complement Neural Modulation

Pairing your neurostimulation sessions with small daily tweaks can seriously boost results. Think of it as giving your device a helping hand. Complementing neural modulation with lifestyle modifications like gentle stretching or walking improves blood flow to the treated area, which can enhance signal delivery. Similarly, sticking to a consistent sleep schedule helps your nervous system reset, making your stim therapy more effective. Even swapping a sugary snack for something with omega-3s, like walnuts, may reduce background inflammation, letting your device work with less interference. These aren’t big overhauls—just smart, friendly habits that let your stimulator do its best job.

Emerging Technologies and Future Directions

Future directions in neurostimulation are moving toward closed-loop systems that adapt in real-time to your pain signals, rather than delivering constant stimulation. Emerging tech like focused ultrasound and optogenetics promises non-invasive or highly targeted nerve modulation, reducing side effects. You’ll soon see implants with wireless recharging and smartphone-controlled settings, letting you tweak therapy without clinic visits. Machine learning algorithms are being developed to predict flare-ups and adjust stimulation proactively. These advances aim to make treatment more intuitive and personalized, shifting from a one-size-fits-all approach to a dynamic system that learns and responds to your unique pain patterns.

Closed-Loop Systems That Adapt to Neural Feedback in Real Time

Closed-loop systems that adapt to neural feedback in real time continuously monitor brain or spinal cord signals to adjust stimulation parameters dynamically. By detecting spontaneous pain-related neural patterns, these systems modulate current intensity or frequency within milliseconds, preventing pain escalation without patient input. This adaptive loop reduces energy consumption compared to open-loop devices by delivering stimulation only when needed. A key advantage is real-time neural adaptation, which minimizes habituation by constantly varying stimulation based on detected pain biomarkers. Users experience fewer breakthrough pain episodes and longer-lasting relief, as the system preemptively alters output before pain thresholds are reached.

Non-Invasive Wearable Devices Gaining Clinical Evidence

Within neurostimulation, non-invasive wearable devices are now accumulating clinical evidence through controlled trials and systematic reviews. High-definition transcranial direct current stimulation (HD-tDCS) headsets, for instance, have demonstrated statistically significant reductions in fibromyalgia pain scores in randomized sham-controlled studies. Similarly, pulsed shortwave therapy devices show consistent efficacy for knee osteoarthritis in prospective cohort analyses. The evidence primarily validates specific parameters—optimal electrode placement, stimulation intensity, and session duration—rather than all device configurations. This data enables clinicians to prescribe targeted, reproducible protocols. Support for clinical evidence validation grows as large-scale longitudinal data confirms sustained analgesic effects without habituation, distinguishing these devices from unproven consumer wearables.

Advances in Electrode Design for More Targeted Coverage

Advances in electrode design now let us dial into pain pathways with surgical precision. High-density arrays pack more contacts onto a single lead, allowing current to shape around specific nerve fibers instead of blasting a wide area. This means we can skirt unwanted side effects like muscle twitching while still covering the exact region of chronic pain. Fractal-based electrode patterns are emerging that mimic natural neural branching for even smoother signal delivery. The shift toward targeted neurostimulation coverage reduces trial-and-error during programming, giving you a more comfortable and effective setup from the start.

In short, smarter electrode layouts let you treat the pain spot without shocking the neighborhood.

Insurance Coverage, Costs, and Access Barriers

Insurance coverage for neurostimulation often hinges on proving you’ve tried and failed less invasive treatments like physical therapy or injections over several months. Even with a green light, out-of-pocket costs for the device and surgery can still run thousands of dollars due to high deductibles or co-insurance. Prior authorization is a major hurdle, with many plans requiring multiple specialist reviews and detailed pain diaries before approval. The trial period adds another layer of expense, as you may pay separate fees for the temporary implant and its removal. A denied claim doesn’t always mean a dead end—persistent appeals with updated medical records sometimes shift the decision in your favor. Access is further limited by the small number of clinics that both accept your insurer and offer this therapy, particularly in rural areas.

Navigating Prior Authorization and Medical Necessity Documentation

Securing coverage begins with a precise medical necessity justification that connects failed conservative therapies directly to neurostimulation’s documented efficacy. Your physician must submit objective evidence—imaging, pain scores, and failed trial outcomes—explicitly linking your condition to the insurer’s specific criteria. Pre-authorization typically requires a psych clearance and a trial period; without these steps, denial is near-certain. Timing your appeal with a bridge letter from your proceduralist can often overturn an initial rejection. Ensure all documentation uses the insurer’s own language verbatim to avoid algorithmic denials.

Out-of-Pocket Expenses for Non-Covered Devices and Maintenance

Patients often face significant out-of-pocket expenses for non-covered neurostimulation devices and maintenance when insurers classify certain models as experimental. This cost burden typically follows a clear sequence.

1. First, the patient must pay the full device acquisition cost, which may exceed $30,000 for advanced systems.
2. Second, ongoing maintenance—such as battery replacements or lead adjustments—is billed directly, often requiring $1,000–$5,000 per procedure.
3. Third, consumables like trial programmers or disposable cables are excluded from standard coverage, adding unpredictable costs.

These financial gaps force patients to choose between inferior covered devices or self-funding premium options, directly limiting access to optimal therapy and creating a two-tier system based on personal liquidity.

Disparities in Access Across Urban and Rural Healthcare Settings

Disparities in access across urban and rural healthcare settings significantly limit neurostimulation adoption for chronic pain. Rural patients often face prohibitive travel distances to urban implant centers, where specialists are concentrated. This creates a sequence of practical barriers: first, geographic isolation prevents initial consultation; second, rural clinics lack the surgical facilities for device implantation; and third, follow-up programming and battery replacements require repeated long trips. Even with insurance coverage, unequal geographic distribution of neurostimulation providers leaves rural populations underserved, as local physicians may lack experience in device management, forcing patients to either travel or forgo the therapy entirely.

1. Travel distance to urban specialists prevents initial evaluation and trial.
2. Implantation requires access to a hospital with specialized surgical and imaging equipment, absent in many rural areas.
3. Ongoing device maintenance, reprogramming, and battery exchanges necessitate repeated long-distance travel.

What This Nerve-Based Approach Does for Persistent Pain

How Electrical Signals Disrupt Pain Transmission

Key Differences Between Spinal Cord Stimulation and Peripheral Nerve Stimulation

Who Benefits Most From Using Neural Modulation

Conditions That Frequently Respond to This Therapy

Ideal Candidate Profile for Successful Outcomes

How to Choose Between Implantable and External Devices

Battery Life, Lead Placement, and Wearable Options Compared

Factors That Influence Long-Term Comfort and Convenience

Step-by-Step Guide to Getting Started With a Device

Trial Periods: What to Expect Before Permanent Implantation

Programming Sessions and Adjusting Stimulation Settings

Practical Tips for Daily Pain Relief and Device Maintenance

Managing Battery Recharging and Lead Positioning

Combining Neurostimulation With Medication or Physical Therapy